RecruitingNCT07539675

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis


Sponsor

Zhongnan Hospital

Enrollment

150 participants

Start Date

Oct 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.


Eligibility

Min Age: 50 Years

Inclusion Criteria5

  • Clinically diagnosed with primary angle-closure glaucoma (PACG)
  • Aged ≥ 50 years, no gender restriction
  • Case Group A: Undergoing glaucoma surgery with intraoperatively confirmed significant zonular laxity
  • Case Group B: Undergoing glaucoma surgery with intraoperatively confirmed normal zonular morphology
  • Control group: age- and sex-matched with case groups; clinically diagnosed with age-related cataract; normal anterior chamber depth and angle; no history or signs of glaucoma; undergoing cataract surgery

Exclusion Criteria5

  • Secondary glaucoma
  • History of previous intraocular surgery
  • Systemic diseases that can cause abnormal ocular zonules
  • Other severe ocular diseases
  • Long-term use of medications affecting connective tissue metabolism

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Additional Experimental Intervention

No Additional Experimental Intervention


Locations(1)

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07539675


Related Trials